ADC Therapeutics (ADCT) Current Leases (2019 - 2023)
ADC Therapeutics (ADCT) posted Current Leases of $1.5 million for Q4 2023, up 3.53% sequentially from $1.4 million in Q3 2023, and up 33.73% YoY from $1.1 million in Q4 2022.
ADC Therapeutics (ADCT) Current Leases (2019 - 2023) Analysis & Trends
ADC Therapeutics has reported Current Leases for 5 years, with the latest figure at $1.5 million in Q4 2023.
- Quarterly Current Leases rose 33.73% year-over-year to $1.5 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.5 million (up 33.73% YoY) and the FY2023 annual result came in at $1.5 million, up 33.73% from the prior year.
- Current Leases rose to $1.5 million in Q4 2023 per ADCT's latest filing, from $1.4 million in the prior quarter.
- Over five years, Current Leases peaked at $1.6 million in Q2 2023 and troughed at $833000.0 in Q1 2021.
- A 5-year average of $1.1 million and a median of $1.0 million in 2021 frame the typical range for Current Leases.
- The sharpest annual moves came in 2021 and 2023: Current Leases fell 25.76% in 2021, then surged 79.54% in 2023.
- Over 5 years, Current Leases stood at $924000.0 in 2019, then climbed by 8.44% to $1.0 million in 2020, then advanced by 2.69% to $1.0 million in 2021, then gained by 6.61% to $1.1 million in 2022, then surged by 33.73% to $1.5 million in 2023.
- According to Business Quant data, Current Leases over the past three periods registered $1.5 million, $1.4 million, and $1.6 million for Q4 2023, Q3 2023, and Q2 2023 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | ADC Therapeutics | 148.95 Mn | -70.15 Mn | 17.14 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | 1.47 Mn |
| Sep 30, 2023 | 1.42 Mn |
| Jun 30, 2023 | 1.63 Mn |
| Mar 31, 2023 | 1.45 Mn |
| Dec 31, 2022 | 1.10 Mn |
| Sep 30, 2022 | 835,000.00 |
| Jun 30, 2022 | 909,000.00 |
| Mar 31, 2022 | 981,000.00 |
| Dec 31, 2021 | 1.03 Mn |
| Sep 30, 2021 | 1.01 Mn |
| Jun 30, 2021 | 988,000.00 |
| Mar 31, 2021 | 833,000.00 |
| Dec 31, 2020 | 1.00 Mn |
| Sep 30, 2020 | 1.05 Mn |
| Jun 30, 2020 | 1.10 Mn |
| Mar 31, 2020 | 1.12 Mn |
| Dec 31, 2019 | 924,000.00 |